<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00987805</url>
  </required_header>
  <id_info>
    <org_study_id>B090029</org_study_id>
    <secondary_id>ISRCTN51910678</secondary_id>
    <nct_id>NCT00987805</nct_id>
  </id_info>
  <brief_title>Efficacy of Banhasasim-tang on Functional Dyspepsia</brief_title>
  <official_title>Efficacy of Banhasasim-tang on Functional Dyspepsia : a Randomized, Double Blind, Placebo Controlled, Two-center Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Korea Health Industry Development Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Korea Health Industry Development Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess efficacy based on Gastrointestinal Symptom score and
      safety based on the rate of adverse event or laboratory findings of Banhasasim-tang
      administrated three times a day orally on functional dyspepsia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Banhasasim-tang

        1. Main 3 gram herb powder (including Rhizoma Pinelliae, Radix Scutellariae, Zingiberis
           Rhizoma, Panax ginseng, Glycyrrhiza uralensis Fisch, Zizyphi Fructus and Coptidis
           Rhizoma) of old oriental prescriptions for dyspepsia.

        2. Usually having used for dyspepsia in asia

        3. Need for correct clinical information by RCT
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gastrointestinal Symptom (GIS) score (epigastric pain/upper abdominal pain, abdominal cramps, fullness, early satiety, loss of appetite, sickness, nausea, vomiting, retrosternal discomfort, and acidic regurgitation/heartburn)</measure>
    <time_frame>Baseline, 2 weeks, 4 weeks, 6 weeks after administration, 4 and 8 weeks after treatment finish</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale (VAS) for overall discomfort due to dyspepsia</measure>
    <time_frame>Baseline, 2weeks, 4weeks, 6weeks after administration, 4 and 8 weeks after treatment finish</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Dyspepsia-related Quality of Life (FD-QoL)</measure>
    <time_frame>Baseline, 2 weeks, 4 weeks, and 6 weeks after administration, 4 and 8 weeks after treatment finish</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electrogastrography (EGG)</measure>
    <time_frame>Baseline, 6 weeks after administration</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">84</enrollment>
  <condition>Functional Dyspepsia</condition>
  <arm_group>
    <arm_group_label>Banhasasim-tang</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo drug</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The placebo of this study is corn-starch granules. It has the same form, color, flavor and amount like experimental herbal extracted formula</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Banhasasim-tang</intervention_name>
    <description>Form : granules Contents : It consists of seven Herbs. It contains Rhizoma Pinelliae, Radix Scutellariae, Zingiberis Rhizoma, Panax ginseng, Glycyrrhiza uralensis Fisch, Zizyphi Fructus and Coptidis Rhizoma Dosage and frequency : 9g per day (three times a day) Route of administration : Oral Administration duration : 42 days in the study</description>
    <arm_group_label>Banhasasim-tang</arm_group_label>
    <other_name>Brand names : Bansasin granules</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Corn-starch granules</intervention_name>
    <description>This placebo has the same form, color, and flavor as experimental intervention.The dosage, frequency and duration is also same as experimental intervention.</description>
    <arm_group_label>Placebo drug</arm_group_label>
    <other_name>Corn-starch granules with herb decoctions flavor</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Typical functional dyspepsia according to ROME III criteria.

               -  One or more of:

                    -  Bothersome post-prandial fullness

                    -  Early satiation

                    -  Epigastric pain

                    -  Epigastric burning

               -  No evidence of structural disease (including at upper endoscopy) that is likely
                  to explain the symptoms

          2. The presence of 'moderate' as the degree of severity for at least three
             Gastrointestinal Symptom (GIS) score symptoms

          3. Before participation of trial, epigastric pain or discomfort has persisted in a
             permanent or recurrent form for a minimum period of 12 weeks

          4. Written and informed consent

        Exclusion Criteria:

          1. History of peptic ulcer or gastroesophageal reflux disease(GERD)

          2. Current prominent symptoms of irritable bowel syndrome or GERD

          3. Presence of the following alarm symptoms:

               -  Severe weight loss

               -  Black or tar stool

               -  Dysphagia

          4. Presence of the following diseases (like cholangitis, pancreatitis, etc.) or
             uncontrolled severe organ disorders

          5. Women in pregnancy and lactation

          6. History of gastrointestinal surgery or taking any drugs that may significantly alter
             digestive system

          7. Participation of other clinical trials within the last 3 months

          8. Severe mental problems or drug abuse

          9. Judged by expert that they are appropriate to participate in this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jin-sung Kim, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kyung Hee University Medical Center Oriental Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kyung Hee University Medical Center Oriental Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>130702</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>East-West Neo Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>134727</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2009</study_first_submitted>
  <study_first_submitted_qc>September 30, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 1, 2009</study_first_posted>
  <last_update_submitted>June 20, 2012</last_update_submitted>
  <last_update_submitted_qc>June 20, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 21, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Korea Health Industry Development Institute</investigator_affiliation>
    <investigator_full_name>Jin-sung Kim</investigator_full_name>
    <investigator_title>Full professor</investigator_title>
  </responsible_party>
  <keyword>Functional dyspepsia</keyword>
  <keyword>Banhasasim-tang</keyword>
  <keyword>Gastrointestinal Symptom score</keyword>
  <keyword>Visual Analogue Scale</keyword>
  <keyword>Functional Dyspepsia-related Quality of Life</keyword>
  <keyword>Electrogastrography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyspepsia</mesh_term>
    <mesh_term>Gastritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

